Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesA meta-analysis of the efficacy and safety of using infliximab for the treatment of rheumatoid arthritis
Clinical Rheumatology, 09/25/09
Wiens A et al. – Infliximab is a chimeric monoclonal antibody. Published studies indicate that its use in patients with rheumatoid arthritis can be efficient in providing long–term benefits. The aim of this study is to evaluate the efficacy and safety of using infliximab for the treatment of rheumatoid arthritis. This meta–analysis shows a higher efficacy of infliximab relative to placebo without significant safety differences between the infliximab–treated and control groups.
Related Articles
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 84%
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 84%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 84%
Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09
Relevance Score: 83%
The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/07/09
Silica exposure among male current smokers is associated with a high risk of developing ACPA positive rheumatoid arthritis
Annals of Rheumatic Diseases, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Sponsor
Article Search
Sponsor